It has been seen that (5R)-5-hydroxytriptolide can inhibit IL-1β, IL-6, and IL-21 secretion and elevated IL-10 secretion in peripheral blood and synovial fluid of RA patients [69]. The gene discussed is IL1B; the disease is rheumatoid arthritis.